UB Paderborn / Katalog / Suche / in CDI

Short- and long-term outcomes in Middle Eastern diabetic patients after percutaneous coronary intervention: results from The First Jordanian PCI Registry (JoPCR1)

Diabetology international, 2017-03, Vol.8 (1), p.30-38

2017

Volltextzugriff (PDF)

One-Year Clinical Outcome in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study

International journal of vascular medicine, 2022-04, Vol.2022, p.4240999-8

2022

Volltextzugriff (PDF)

Adherence to the 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline on the Use of Oral Anticoagulant Agents in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study

International journal of vascular medicine, 2021, Vol.2021, p.5515089-9

2021

Volltextzugriff (PDF)

A Jordanian Multidisciplinary Consensus Statement on the Management of Dyslipidemia

Journal of clinical medicine, 2023-06, Vol.12 (13), p.4312

2023

Volltextzugriff (PDF)

Reality of obesity paradox: Results of percutaneous coronary intervention in Middle Eastern patients

Journal of international medical research, 2018-04, Vol.46 (4), p.1595-1605

2018

Volltextzugriff (PDF)

Cardiovascular risk factors in Middle Eastern patients undergoing percutaneous coronary intervention: Results from the first Jordanian percutaneous coronary intervention study

Journal Of The Saudi Heart Association, 2017-07, Vol.29 (3), p.195-202

2017

Volltextzugriff (PDF)

One-year outcome after percutaneous coronary intervention in Middle Eastern elderly patients

Asian journal of gerontology and geriatrics, 2017-06, Vol.12 (1), p.23-28

2017

Volltextzugriff (PDF)

Outcomes of Middle Eastern Patients Undergoing Percutaneous Coronary Intervention: The Primary Analysis of the First Jordanian PCI Registry

Heart views, 2017-01, Vol.18 (1), p.3-7

2017

Volltextzugriff (PDF)

TICAGRELOR INDUCED PULMONARY HEMORRHAGE - A RARE ENTITY NECESSITATING PROMPT RECOGNITION

Journal of the American College of Cardiology, 2024-04, Vol.83 (13), p.3292-3292

2024

Volltextzugriff (PDF)

ADHERENCE TO THE 2019 FOCUSED UPDATE OF THE 2014 AHA/ACC/HRS GUIDELINE ON THE USE OF ORAL ANTICOAGULANT AGENTS IN PATIENTS WITH ATRIAL FIBRILLATION IN THE MIDDLE EAST: THE JORDAN ATRIAL FIBRILLATION STUDY

Journal of the American College of Cardiology, 2021-05, Vol.77 (18), p.1520-1520

2021

Volltextzugriff (PDF)

The therapeutic potential of ximelagatran to become the anticoagulant of choice in medicine: a review of recently completed clinical trials

Expert opinion on pharmacotherapy, 2004-06, Vol.5 (6), p.1423-1430

2004

Volltextzugriff (PDF)

Incidence and impact on prognosis of impaired kidney function in Middle Eastern patients undergoing percutaneous coronary intervention: results from the first Jordanian PCI Registry

AsiaIntervention, 2019-02, Vol.5 (1), p.18-26

2019

Volltextzugriff (PDF)

Immunological changes in acute myocardial infarction

Saudi medical journal, 2004-07, Vol.25 (7), p.923

2004

Volltextzugriff (PDF)

Successful treatment of Brucella endocarditis with aortic root abscess

Saudi medical journal, 2005-03, Vol.26 (3), p.473

2005

Volltextzugriff (PDF)

Angioplasty Guidewire Velocity: A New Simple Method to Calculate Absolute Coronary Blood Velocity and Flow

The American journal of cardiology, 1997-12, Vol.80 (12), p.1536-1539

1997

Volltextzugriff (PDF)

Hypertension and its management in countries in Africa and the Middle East, with special reference to the place of β-blockade

Current medical research and opinion, 2011-06, Vol.27 (6), p.1223-1236

2011

Volltextzugriff (PDF)

Effect of oral mecobalamin treatment on chest pain in patients with cobalamin deficiency and no evidence of coronary artery disease. A randomized, placebo-controlled trial

Saudi medical journal, 2005-07, Vol.26 (7), p.1144

2005

Volltextzugriff (PDF)

Incidence and impact on prognosis of heart failure in Middle Eastern patients undergoing percutaneous coronary interventions

Asian Journal of Medical Sciences, 2017-03, Vol.8 (2), p.20-28

2017

Volltextzugriff (PDF)

APSC2015-1016 Major Bleeding Events Among Middle Eastern Patients Undergoing PCI: Clinical Profiles and 1-Month Outcome. Results from the First Jordanian PCI Registry (JOPCR 1)

Global heart, 2015-06, Vol.10 (2), p.e26-e26

2015

Volltextzugriff (PDF)

Glycoprotein IIb/IIIa receptor inhibition in interventional cardiology

Journal of thrombosis and thrombolysis, 1999-06, Vol.7 (3), p.287

1999

Volltextzugriff (PDF)

Prevalence of conventional risk factors in Jordanians with coronary heart disease: The Jordan Hyperlipidemia and Related Targets Study (JoHARTS)

International journal of cardiology, 2006-06, Vol.110 (2), p.179-183

2006

Volltextzugriff (PDF)

Prevalence and impact on prognosis of glucometabolic states in acute coronary syndrome in a middle eastern country: The GLucometabolic abnOrmalities in patients with acute coronaRY syndrome in Jordan (GLORY) study

International journal of diabetes in developing countries, 2012-03, Vol.32 (1), p.37-43

2012

Volltextzugriff (PDF)

Utilization of reperfusion therapy in the Myocardial INfarction Triggers and Onset in JoRdan (MINTOR) study

International journal of cardiology, 2007-11, Vol.122 (2), p.156-157

2007

Volltextzugriff (PDF)

Utilization of reperfusion therapy in the M yocardial IN farction T riggers and O nset in Jo R dan ( MINTOR ) study

International journal of cardiology, 2007, Vol.122 (2), p.156-157

2007

Volltextzugriff (PDF)

Utilization of reperfusion therapy in the Myocardial INfarction Triggers and Onset in Jo Rdan ( MINTOR) study

International journal of cardiology, 2007, Vol.122 (2), p.156-157

2007

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Short- and long-term outcomes in Middle Eastern diabetic patients after percutaneous coronary intervention: results from The First Jordanian PCI Registry (JoPCR1)

One-Year Clinical Outcome in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study

Adherence to the 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline on the Use of Oral Anticoagulant Agents in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study

A Jordanian Multidisciplinary Consensus Statement on the Management of Dyslipidemia

Reality of obesity paradox: Results of percutaneous coronary intervention in Middle Eastern patients

Cardiovascular risk factors in Middle Eastern patients undergoing percutaneous coronary intervention: Results from the first Jordanian percutaneous coronary intervention study

One-year outcome after percutaneous coronary intervention in Middle Eastern elderly patients

Outcomes of Middle Eastern Patients Undergoing Percutaneous Coronary Intervention: The Primary Analysis of the First Jordanian PCI Registry

TICAGRELOR INDUCED PULMONARY HEMORRHAGE - A RARE ENTITY NECESSITATING PROMPT RECOGNITION

ADHERENCE TO THE 2019 FOCUSED UPDATE OF THE 2014 AHA/ACC/HRS GUIDELINE ON THE USE OF ORAL ANTICOAGULANT AGENTS IN PATIENTS WITH ATRIAL FIBRILLATION IN THE MIDDLE EAST: THE JORDAN ATRIAL FIBRILLATION STUDY

The therapeutic potential of ximelagatran to become the anticoagulant of choice in medicine: a review of recently completed clinical trials

Incidence and impact on prognosis of impaired kidney function in Middle Eastern patients undergoing percutaneous coronary intervention: results from the first Jordanian PCI Registry

Immunological changes in acute myocardial infarction

Successful treatment of Brucella endocarditis with aortic root abscess

Angioplasty Guidewire Velocity: A New Simple Method to Calculate Absolute Coronary Blood Velocity and Flow

Hypertension and its management in countries in Africa and the Middle East, with special reference to the place of β-blockade

Effect of oral mecobalamin treatment on chest pain in patients with cobalamin deficiency and no evidence of coronary artery disease. A randomized, placebo-controlled trial

Incidence and impact on prognosis of heart failure in Middle Eastern patients undergoing percutaneous coronary interventions

APSC2015-1016 Major Bleeding Events Among Middle Eastern Patients Undergoing PCI: Clinical Profiles and 1-Month Outcome. Results from the First Jordanian PCI Registry (JOPCR 1)

Glycoprotein IIb/IIIa receptor inhibition in interventional cardiology

Prevalence of conventional risk factors in Jordanians with coronary heart disease: The Jordan Hyperlipidemia and Related Targets Study (JoHARTS)

Prevalence and impact on prognosis of glucometabolic states in acute coronary syndrome in a middle eastern country: The GLucometabolic abnOrmalities in patients with acute coronaRY syndrome in Jordan (GLORY) study

Utilization of reperfusion therapy in the Myocardial INfarction Triggers and Onset in JoRdan (MINTOR) study

Utilization of reperfusion therapy in the M yocardial IN farction T riggers and O nset in Jo R dan ( MINTOR ) study

Utilization of reperfusion therapy in the Myocardial INfarction Triggers and Onset in Jo Rdan ( MINTOR) study

Suchergebnisse filtern